Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ChoongAng Vaccine Laboratories (CAVAC) is a leading South Korean animal health company specializing in the development, manufacture, and distribution of veterinary vaccines. Established in 1968, the company provides a comprehensive portfolio of products targeting swine, poultry, bovine, and companion animal diseases. CAVAC is known for its advanced R&D capabilities and high-quality manufacturing standards, exporting its products to over 20 countries worldwide. Their product line includes well-known brands like SuiShot and PoxiShot, focusing on preventing infectious diseases in livestock and pets. The company is listed on the KOSDAQ and maintains a strong commitment to biosecurity and animal welfare through innovative immunological solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ChoongAng Vaccine Laboratories.